VHT ETF Analysis

For informational purposes only. Not financial advice.

Quick Answer

VHT offers exposure to the health care sector. Its top holding is Eli Lilly and Co (LLY) at 12.70%.

With a 1.03% dividend yield and a beta of 0.73, VHT provides a focused, relatively low-volatility approach to investing in health care. Past performance does not guarantee future results.

VHT ETF — Price, Holdings & Analysis

VHT offers exposure to the health care sector. Its top holding is Eli Lilly and Co (LLY) at 12.70%. With a 1.03% dividend yield and a beta of 0.73, VHT provides a focused, relatively low-volatility approach to investing in health care. Past performance does not guarantee future results.

ETF Overview

VHT provides targeted exposure to the health care sector. The fund's strategy focuses on large-cap companies, with Eli Lilly and Co (LLY) representing the largest allocation at 12.70%, followed by Johnson & Johnson (JNJ) at 8.22% and AbbVie Inc (ABBV) at 6.00%. This concentrated approach allows investors to gain specific exposure to leading companies within the pharmaceutical, biotechnology, and health care equipment industries. The fund's selection methodology prioritizes established companies with significant market capitalization, potentially offering stability compared to broader health care ETFs. VHT may appeal to investors seeking a focused approach to health care investing, but its concentrated nature warrants careful consideration. Past performance does not guarantee future results.

Risk Metrics

VHT's concentrated portfolio introduces a higher level of concentration risk compared to more diversified health care ETFs. The top holding, Eli Lilly and Co (LLY), accounts for 12.70% of the fund, meaning its performance significantly impacts VHT's overall returns. The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations. Investors should also consider the potential impact of regulatory changes and drug pricing pressures on the pharmaceutical and biotechnology industries, which could disproportionately affect VHT due to its sector focus. Past performance does not guarantee future results.

What does VHT hold?

Holding	Weight
Eli Lilly and Co (LLY)	12.70%
Johnson & Johnson (JNJ)	8.22%
AbbVie Inc (ABBV)	6.00%
Merck & Co Inc (MRK)	4.19%
UnitedHealth Group Inc (UNH)	3.96%
Thermo Fisher Scientific Inc (TMO)	3.33%
Abbott Laboratories (ABT)	2.90%
Amgen Inc (AMGN)	2.80%
Intuitive Surgical Inc (ISRG)	2.75%
Gilead Sciences Inc (GILD)	2.68%

Dividend Yield

1.03%

Risk Metrics

Beta: 0.73

Questions & Answers

What is VHT and what does it track?

VHT is an exchange-traded fund (ETF) that provides focused exposure to the health care sector. Unlike broader health care ETFs, VHT holds a very.

The fund's top holdings include companies like Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV).

What are the top holdings in VHT?

VHT's top holdings are heavily weighted towards leading companies in the pharmaceutical and health care sectors.

As of 2026-03-15, the top three holdings are Eli Lilly and Co (LLY) at 12.70%, Johnson & Johnson (JNJ) at 8.22%, and AbbVie Inc (ABBV) at 6.00%.

Is VHT a good long-term investment?

Whether VHT is a suitable long-term investment depends on an individual investor's risk tolerance, investment objectives, and time horizon. VHT offers focused exposure to the health care sector through a concentrated portfolio.

The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations.

How does VHT compare to similar ETFs?

VHT distinguishes itself from other health care ETFs through its highly.

While specific expense ratio and AUM data are unavailable, the fund's strategy of focusing on a small number of large-cap companies sets it apart from more diversified health care ETFs. Investors seeking targeted exposure to leading companies within the pharmaceutical and biotechnology industries may find VHT appealing.

Does VHT pay dividends?

Yes, VHT distributes dividends to its shareholders. As of 2026-03-15, VHT has a dividend yield of 1.03%. The dividend yield represents the annual dividend income received from the fund, expressed as a percentage of the fund's net asset value.

Investors seeking income from their investments may find VHT's dividend yield attractive, but it's important to note that dividend yields can fluctuate over time. Past performance does not guarantee future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

Written by machine, not reviewed page by page. Editorial oversight is systemic: the rules and the sources are checked, individual pages are not.